Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Archive

Proactive news headlines: Seeing Machines, OKYO Pharma, Open Orphan, Union Jack and more

Ora Banda Mining Ltd (ASX:OBM) has completed a A$5 million institutional placement and a A$7.7 million institutional entitlement offer.

The company received firm commitments of A$5 million for its placement of new fully paid ordinary shares to sophisticated and professional investors and around A$7.7 million for the institutional component of its 4-for-13 accelerated non-renounceable pro-rata entitlement offer.

Read more

Helium One Global Ltd (AIM:HE1, OTCQB:HLOGF) shares are underappreciated in the market, according to stockbroker Liberum, which has begun its coverage of the exploration company with a ‘buy’ recommendation.

“Helium One’s current share price performance does not fully reflect the work done to date by the company, in our view,” the broker said in a note.

Read more

Faron Pharmaceuticals Ltd has reported more data indicating longer survival rates for late-stage cancer sufferers treated with its new drug bexmarilimab.

Updated results from the ongoing phase I/II MATINS trial showed 70% of patients receiving the drug had survived nine months compared with 26% for those not treated.

Read more

Seeing Machines Limited reported underlying growth in revenues of almost 25% in its latest half-year and said opportunities for its driver monitoring (DMS) technology are accelerating across the entire product range.

Read more

OKYO Pharma Ltd said it has been issued a US patent for its dry eye disease candidate (DED) OK-101.

The key claim in the application covered the drug’s use to treat neuropathic pain.

Read more

Incanthera PLC (AQSE:INC) has appointed Caroline Murray as a non-executive director with immediate effect. Murray, who previously held senior positions at Novartis and Bristol Myers Squibb, brings “extensive product management and marketing experience to the board,” a statement from the oncology drug developer said.

Live Company Group PLC (AIM:LVCG) has announced the final two acts for the second day of its KPOP.FLEX festival in Frankfurt this May. Mamamoo, a four-member girl band and Dreamcatcher, a seven-member girl band will be performing on day two of the event, which has sold roughly 13,000 tickets so far.

Anglesey Mining PLC (LSE:AYM) chief executive Jo Battershill has topped up his personal holding in the miner with the purchase of roughly 199,000 shares at an average price of 3.3p each. Battershill now holds around 1.787mln shares in total or 0.8% of the junior’s share capital.

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK